16 September

Democracy violation: European Commission rejects citizens’ initiative to stop TTIP and CETA

15 July

School's IN for summer: HAI staff and interns inspired by Utrecht University's course on pharmaceutical policy analysis

11 June

BMJ statins debate about scientific independence, not rigour

28 May

Progress on access to medicines at WHA67, but WHO funding sorely needed

26 May

World Health Assembly 67: HAI and KEI intervention on the Consultative Expert Working Group on Research and Development

26 May

World Health Assembly 67: HAI intervention on access to essential medicines

20 May

World Health Assembly 67: HAI intervention on the WHO's framework of engagement with non-state actors

10 April

Tamiflu review shows desperate need for full clinical trials data transparency

7 April

Governments must ensure Big Pharma’s expansion in Africa doesn’t impede generics supply

3 March

New materials help assess medicines policies and interventions

24 February

A new (and improved) model to regulate pharmaceutical promotion

12 February

Enhancing accountability in the medicines market: The Medicines Transparency Alliance

31 January

Bayer CEO's callous comments highlight failure of current biomedical innovation model

25 November

When politicians go to the movies

12 July

DG Trade State of Play reveals EU's ambitions for IP protection in FTAs